TAMMY DONNICK: Open Payments
NPI 1760120877 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 10 payments from 5 companies in 2025. Trend: 2023 $67 · 2024 $48 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $53 |
| Novo Nordisk Inc | 3 | $49 |
| Amgen Inc. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: MOUNJARO, Ozempic, Veozah, Repatha, OTEZLA, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
